Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonie Beyer

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Science Translational Medicine|October 13, 2021
Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseasesXianyuan Xiang, Karin Wind, Thomas Wiedemann, et al.
Frontiers in Oncology|February 16, 2023
Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [<sup>18</sup>F]SiTATERalf S Eschbach, Markus Hofmann, Lukas Späth, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 27, 2020
In Vivo Assessment of Neuroinflammation in 4-Repeat TauopathiesCarla Palleis, Julia Sauerbeck, Leonie Beyer, et al.
Journal of Neuroinflammation|March 11, 2023
[<sup>18</sup>F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human dataAnna Ballweg, Carolin Klaus, Letizia Vogler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2022
<sup>18</sup>F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear PalsyKonstantin Messerschmidt, Henryk Barthel, Matthias Brendel, et al.
Acta Neuropathologica|November 24, 2024
Neuronal and oligodendroglial, but not astroglial, tau translates to in vivo tau PET signals in individuals with primary tauopathiesLuna Slemann, Johannes Gnörich, Selina Hummel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 22, 2021
Feasibility of short imaging protocols for [<sup>18</sup>F]PI-2620 tau-PET in progressive supranuclear palsyMengmeng Song, Maximilian Scheifele, Henryk Barthel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 23, 2020
Early-phase [<sup>18</sup>F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injuryLeonie Beyer, Alexander Nitschmann, Henryk Barthel, et al.
JAMA Neurology|November 9, 2020
Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear PalsyMatthias Brendel, Henryk Barthel, Thilo van Eimeren, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2023
Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmissionAnna Stockbauer, Leonie Beyer, Maria Huber, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Science Translational Medicine|October 13, 2021
Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseasesXianyuan Xiang, Karin Wind, Thomas Wiedemann, et al.
Frontiers in Oncology|February 16, 2023
Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [<sup>18</sup>F]SiTATERalf S Eschbach, Markus Hofmann, Lukas Späth, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 27, 2020
In Vivo Assessment of Neuroinflammation in 4-Repeat TauopathiesCarla Palleis, Julia Sauerbeck, Leonie Beyer, et al.
Journal of Neuroinflammation|March 11, 2023
[<sup>18</sup>F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human dataAnna Ballweg, Carolin Klaus, Letizia Vogler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2022
<sup>18</sup>F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear PalsyKonstantin Messerschmidt, Henryk Barthel, Matthias Brendel, et al.
Acta Neuropathologica|November 24, 2024
Neuronal and oligodendroglial, but not astroglial, tau translates to in vivo tau PET signals in individuals with primary tauopathiesLuna Slemann, Johannes Gnörich, Selina Hummel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 22, 2021
Feasibility of short imaging protocols for [<sup>18</sup>F]PI-2620 tau-PET in progressive supranuclear palsyMengmeng Song, Maximilian Scheifele, Henryk Barthel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 23, 2020
Early-phase [<sup>18</sup>F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injuryLeonie Beyer, Alexander Nitschmann, Henryk Barthel, et al.
JAMA Neurology|November 9, 2020
Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear PalsyMatthias Brendel, Henryk Barthel, Thilo van Eimeren, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2023
Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmissionAnna Stockbauer, Leonie Beyer, Maria Huber, et al.
Pageof 8